Add to ORKGCopyright © 2013 B. Aigner et al.This is an open access article distributed under the Creative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Palmoplantar erythrodysesthesia is an uncommon localised cutaneous reaction to certain chemotherapeutic agents and characterized by painful palmoplantar erythema and dysesthesia. To the best of our knowledge, we report the first case of plantar erythrodysesthesia in a 40-year-old male patient receiving an antiretroviral combination therapy for HIV. 1
PubMedID: 16188440Palmar-plantar erythrodysesthesia (PPE) is a distinctive and relatively frequent t...
Aims: to identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving peg...
Objective. To provide a comprehensive review of the chemotherapy induced dermatological toxicity, pa...
Palmar-Plantar Erythrodysesthesia (PPE) (or) Burgdorf’s Reaction (BR) (or) Hand-Foot Syndrome (HFS) ...
Abstract Introduction Docetaxel is a chemotherapeutic agent used alone or in combination for the man...
Palmar-plantar erythrodysesthesia (PPE), also called hand-foot syndrome, is a relatively common derm...
We report a case of a 62 year-old patient who developed Palmar-plantar erythrodysesthesia upon recei...
Palmar-plantar erythrodysesthesia (PPE) is a distinc-tive, localized cutaneous response to certain s...
Palmar plantar erythrodysesthesia is a cutaneous drug reaction induced by chemotherapy. We present a...
Palmar-plantar erthrodyesthesia (PPE) (hand and foot syndrome) is a dermatological toxic reaction re...
Pegylated liposomal doxorubicin (PLD) is an intravenous antineoplastic agent in which a polyethylene...
Palmar-plantar eritrodisestezi (PPE) (el-ayak sendromu) bazı kemoteröpötik ilaçlar ile ilişkili derm...
Purpose: To describe lipoatrophy of the plantar pedis fat pads in human immunodeficiency virus (HIV)...
Aims: To identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
PubMedID: 16188440Palmar-plantar erythrodysesthesia (PPE) is a distinctive and relatively frequent t...
Aims: to identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving peg...
Objective. To provide a comprehensive review of the chemotherapy induced dermatological toxicity, pa...
Palmar-Plantar Erythrodysesthesia (PPE) (or) Burgdorf’s Reaction (BR) (or) Hand-Foot Syndrome (HFS) ...
Abstract Introduction Docetaxel is a chemotherapeutic agent used alone or in combination for the man...
Palmar-plantar erythrodysesthesia (PPE), also called hand-foot syndrome, is a relatively common derm...
We report a case of a 62 year-old patient who developed Palmar-plantar erythrodysesthesia upon recei...
Palmar-plantar erythrodysesthesia (PPE) is a distinc-tive, localized cutaneous response to certain s...
Palmar plantar erythrodysesthesia is a cutaneous drug reaction induced by chemotherapy. We present a...
Palmar-plantar erthrodyesthesia (PPE) (hand and foot syndrome) is a dermatological toxic reaction re...
Pegylated liposomal doxorubicin (PLD) is an intravenous antineoplastic agent in which a polyethylene...
Palmar-plantar eritrodisestezi (PPE) (el-ayak sendromu) bazı kemoteröpötik ilaçlar ile ilişkili derm...
Purpose: To describe lipoatrophy of the plantar pedis fat pads in human immunodeficiency virus (HIV)...
Aims: To identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
PubMedID: 16188440Palmar-plantar erythrodysesthesia (PPE) is a distinctive and relatively frequent t...
Aims: to identify pre-treatment risk factors for the development of Palmar Plantar Erythrodysesthesi...
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving peg...